Cargando…
Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results
Aim: This study aimed to present the short- and long-term results of Demirtas two-step treatment model in patients with obstructed-hydronephrotic kidneys functioning below 10%, and before deciding on nephrectomy, to evaluate whether this method can contribute to the accurate assessment. Material and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298605/ https://www.ncbi.nlm.nih.gov/pubmed/35875311 http://dx.doi.org/10.7759/cureus.26128 |
_version_ | 1784750745520701440 |
---|---|
author | Demirtaş, Abdullah Golbasi, Abdullah Guleser, Ahmet S Sönmez, Gökhan Demirtaş, Türev GÜR, Ahmet Tombul, Şevket T |
author_facet | Demirtaş, Abdullah Golbasi, Abdullah Guleser, Ahmet S Sönmez, Gökhan Demirtaş, Türev GÜR, Ahmet Tombul, Şevket T |
author_sort | Demirtaş, Abdullah |
collection | PubMed |
description | Aim: This study aimed to present the short- and long-term results of Demirtas two-step treatment model in patients with obstructed-hydronephrotic kidneys functioning below 10%, and before deciding on nephrectomy, to evaluate whether this method can contribute to the accurate assessment. Material and methods: This prospective study included patients with unilateral renal obstruction and renal parenchymal loss assessed by computed tomography and whose renal function was found to be below 10% in Tc-99m-dimercaptosuccinic acid. In the first step, percutaneous nephrostomy (PCN) was performed. Two weeks later, the second step was performed, in which patients were offered nephrectomy (if renal function was <10%) or etiology-based treatment (if renal function was ≥10%). Results: Thirty-eight patients were included in the study, comprising 20 (52.6%) men and 18 (47.4%) women with a mean age of 51.3±16.8 years. Mean baseline renal function was 6.0%, which increased to 10.8% two weeks after PCN (p=0.001). Renal function increased to above 10% in 20 (52.6%) out of 38 patients. Of these, 17 patients underwent etiology-based treatment and baseline, two-week, and 12-month renal function levels were 7.0%, 17.5%, and 18.8%, respectively (p<0.001). Conclusion: Demirtas two-step treatment model introduced in the present study can be recommended as a standard treatment modality in unilaterally obstructed kidneys functioning below 10% ability. |
format | Online Article Text |
id | pubmed-9298605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-92986052022-07-22 Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results Demirtaş, Abdullah Golbasi, Abdullah Guleser, Ahmet S Sönmez, Gökhan Demirtaş, Türev GÜR, Ahmet Tombul, Şevket T Cureus Urology Aim: This study aimed to present the short- and long-term results of Demirtas two-step treatment model in patients with obstructed-hydronephrotic kidneys functioning below 10%, and before deciding on nephrectomy, to evaluate whether this method can contribute to the accurate assessment. Material and methods: This prospective study included patients with unilateral renal obstruction and renal parenchymal loss assessed by computed tomography and whose renal function was found to be below 10% in Tc-99m-dimercaptosuccinic acid. In the first step, percutaneous nephrostomy (PCN) was performed. Two weeks later, the second step was performed, in which patients were offered nephrectomy (if renal function was <10%) or etiology-based treatment (if renal function was ≥10%). Results: Thirty-eight patients were included in the study, comprising 20 (52.6%) men and 18 (47.4%) women with a mean age of 51.3±16.8 years. Mean baseline renal function was 6.0%, which increased to 10.8% two weeks after PCN (p=0.001). Renal function increased to above 10% in 20 (52.6%) out of 38 patients. Of these, 17 patients underwent etiology-based treatment and baseline, two-week, and 12-month renal function levels were 7.0%, 17.5%, and 18.8%, respectively (p<0.001). Conclusion: Demirtas two-step treatment model introduced in the present study can be recommended as a standard treatment modality in unilaterally obstructed kidneys functioning below 10% ability. Cureus 2022-06-20 /pmc/articles/PMC9298605/ /pubmed/35875311 http://dx.doi.org/10.7759/cureus.26128 Text en Copyright © 2022, Demirtaş et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Urology Demirtaş, Abdullah Golbasi, Abdullah Guleser, Ahmet S Sönmez, Gökhan Demirtaş, Türev GÜR, Ahmet Tombul, Şevket T Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results |
title | Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results |
title_full | Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results |
title_fullStr | Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results |
title_full_unstemmed | Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results |
title_short | Demirtas Two-Step Treatment Model in Hypofunctional-Obstructed Kidneys: An Extended Series and Long-Term Prospective Results |
title_sort | demirtas two-step treatment model in hypofunctional-obstructed kidneys: an extended series and long-term prospective results |
topic | Urology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298605/ https://www.ncbi.nlm.nih.gov/pubmed/35875311 http://dx.doi.org/10.7759/cureus.26128 |
work_keys_str_mv | AT demirtasabdullah demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults AT golbasiabdullah demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults AT guleserahmets demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults AT sonmezgokhan demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults AT demirtasturev demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults AT gurahmet demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults AT tombulsevkett demirtastwosteptreatmentmodelinhypofunctionalobstructedkidneysanextendedseriesandlongtermprospectiveresults |